The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
Francesca Tentori, F. K. Port(SHOWA Medical University), Justin M. Albert(Arbor Research Collaborative for Health), T. Akiba(Tokyo Women's Medical University), Roger Greenwood, Rajiv Saran(University of Michigan), Margaret J. Blayney(Arbor Research Collaborative for Health), Nathan W. Levin(Renal Research Institute), LLUIS PIERA, Naoki Kimata(Japanese Society for Dialysis Therapy), Robert A. Wolfe(University of Michigan–Ann Arbor), Bruce Robinson(The University of Sydney), Eric W. Young(SHOWA Medical University), R. L. Pisoni(Arbor Research Collaborative for Health)
Cited by 151
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
|American Journal of Kidney Diseases|1998|2.4k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2006|628
Body fluid volume determination via body composition spectroscopy in health and disease
|Physiological Measurement|2006|608